TCRX Skyrocketed

Thu, Sep 23, 2021 at 05:30 PM

TCRX (TCRX:NASDAQ) jumped higher at $7.69, a gain of 24.6%. On Wed, Sep 22, 2021, TCRX:NASDAQ hit a New 2-Week Low of $6.17. The stock got featured on our News Catalysts scanner on Thu, Sep 02, 2021 at 07:41 AM in the 'MISCELLANEOUS' category. From Wed, Sep 08, 2021, the stock recorded 20.00% Up Days and 18.18% Green Days

The stock spiked on Wed, Aug 18, 2021 at $14.71 with a volume of 16M+.

About TCRX (TCRX:NASDAQ)

TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer.

Top 10 Gainers:

MRM (MRM:NASDAQ), 73.44%
RNAZ (RNAZ:NASDAQ), 53.44%
Four Seasons Education (Cayman) Inc. (FEDU:NYSE), 43.1%
Amplitude Healthcare Acquisition Corporation (AMHC:NASDAQ), 40.37%
Camber Energy, Inc. (CEI:NYSEMKT), 30.14%
Northern Dynasty Minerals Ltd. (NAK:NYSEMKT), 27.89%
AeroCentury Corp. (ACY:NYSEMKT), 27.35%
TCRX (TCRX:NASDAQ), 24.64%
ReWalk Robotics Ltd. (RWLK:NASDAQ), 21.23%
DATS (DATS:NASDAQ), 20.35%